B-cell epitope mapping of Helicobacter pylori neutrophil-activating protein

被引:0
|
作者
Gong, Chibing [1 ]
Li, Yan [2 ]
Li, Ming [2 ]
Luo, Jun [3 ]
Cao, Hong [3 ]
Long, Min [3 ]
机构
[1] Guangdong Tech Coll Water Resource & Elect Engn, Dept Comp Informat Engn, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Biotechnol, Guangzhou, Peoples R China
[3] Southern Med Univ, Microbiol Dept, Guangzhou, Peoples R China
关键词
D O I
10.1109/FBIT.2007.28
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Helicobacter pylori is a major cause of chronic gastritis, peptic ulcer disease, and associated with gastric carcinoma. H. pylori Neutrophil-activating protein (HP-NAP) is one of the major virulence factors. It has been shown that HP-NAP is a good candidate antigen for a multi-epitopes vaccine against H. pylori. However, the B-cell epitopes of HP-NAP are largely unknown. Bioinformatic and immunological approaches are used to map B-cell epitopes of this antigen. Four high antigenic peptides located in different regions were found by B cell epitope prediction. Three mAbs were produced by using recombinant HP-NAP-GST as the immunogen by the standard hybridoma technique. The immunohistochemical staining showed that mAbs against HP-NAP specifically reacted with clinical strains of H. pylori. Three different mimicry B-cell epitopes as mimotopes of HP-NAP protein are identified through screening the phage displayed peptide libraries with these mAbs.
引用
收藏
页码:261 / +
页数:3
相关论文
共 50 条
  • [21] Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils
    Cappon, Andrea
    Babolin, Chiara
    Segat, Daniela
    Cancian, Laila
    Amedei, Amedeo
    Calzetti, Federica
    Cassatella, Marco A.
    D'Elios, Mario M.
    de Bernard, Marina
    CELLULAR MICROBIOLOGY, 2010, 12 (06) : 754 - 764
  • [22] The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses
    Amedei, A
    Cappon, A
    Codolo, G
    Cabrelle, A
    Polenghi, A
    Benagiano, M
    Tasca, E
    Azzurri, A
    D'Elios, MM
    Del Prete, G
    de Bernard, M
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (04): : 1092 - 1101
  • [23] Helicobacter pylori neutrophil-activating protein: a potential Treg modulator suppressing allergic asthma?
    Sehrawat, Anjna
    Sinhaand, Siddharth
    Saxena, Abhishek
    FRONTIERS IN MICROBIOLOGY, 2015, 6
  • [24] Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer
    Long, Min
    Luo, Jun
    Li, Yan
    Zeng, Fang-Yin
    Li, Ming
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (19) : 2381 - 2388
  • [26] A new crystal lattice structure of Helicobacter pylori neutrophil-activating protein (HP-NAP)
    Tsuruta, Osamu
    Yokoyama, Hideshi
    Fujii, Satoshi
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2012, 68 : 134 - 140
  • [27] Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein
    Iankov, Ianko D.
    Penheiter, Alan R.
    Carlson, Stephanie K.
    Galanis, Evanthia
    JOURNAL OF IMMUNOLOGICAL METHODS, 2012, 384 (1-2) : 1 - 9
  • [28] The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells
    Montemurro, P
    Nishioka, H
    Dundon, WG
    de Bernard, M
    Del Giudice, G
    Rappuoli, R
    Montecucco, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (03) : 671 - 676
  • [29] EFFECT OF RECOMBINANT NEUTROPHIL-ACTIVATING PROTEIN (HP-NAP) OF HELICOBACTER PYLORI ON PERITONEAL MACROPHAGES
    Soleimani, Neda
    Mobarez, Ashraf Mohabati
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 : 234 - 234
  • [30] Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus
    Iankov, Ianko D.
    Allen, Cory
    Federspiel, Mark J.
    Myers, Rae M.
    Peng, Kah Whye
    Ingle, James N.
    Russell, Stephen J.
    Galanis, Evanthia
    MOLECULAR THERAPY, 2012, 20 (06) : 1139 - 1147